No Data
Guangdong Hec Technology Holding (600673.SH): has accumulated a buyback of 1.03% of shares.
Gelonghui, January 10丨Guangdong Hec Technology Holding (600673.SH) announced that as of January 10, 2025, the company has repurchased a total of 30,893,475 shares, accounting for 1.03% of the company's current total equity. The lowest purchase price was 6.40 yuan/share and the highest price was 12.67 yuan/share, with a total payment of 317.9582 million yuan (excluding trade fees).
Investors Appear Satisfied With Guangdong HEC Technology Holding Co., Ltd's (SHSE:600673) Prospects As Shares Rocket 51%
The sudden outbreak of H1N1 has ignited the sector against influenza, with HEC CJ PHARM (01558), holding the king of influenza, ready to take action.
Among the sample companies selling Oseltamivir formulations in the domestic market, HEC CJ PHARM's "Kewei" series products consistently maintain the top market share. As the influenza epidemic continues to escalate, HEC CJ PHARM's stock, being a key symbol in the Hong Kong stock market against Influenza, is also set to rise.
Returns On Capital Signal Difficult Times Ahead For Guangdong HEC Technology Holding (SHSE:600673)
Hong Kong stocks movement | HEC CJ PHARM (01558) rises over 6% as the high incidence of influenza boosts the sales of Oseltamivir and other medications.
HEC CJ PHARM (01558) rose over 6%, as of the time of reporting, up 6.54%, trading at 9.94 HKD, with a transaction amount of 21.0847 million HKD.
Hefei Taihe Intelligent Technology Group (603656.SH) controlling shareholder Guangdong Hec Technology Holding has cumulatively increased its Shareholding by 1%.
Hefei Taihe Intelligent Technology Group (603656.SH) announced that the company's controlling shareholder Guangdong Hec Technology Holding will be holding shares until December 27, 2024...
Should We Be Cautious About Guangdong HEC Technology Holding Co., Ltd's (SHSE:600673) ROE Of 2.8%?
No Data
